Cimzia (certolizumab pegol) is a biologic DMARD used to treat rheumatoid arthritis. It works by inhibiting TNF-α, a chemical involved in autoimmune attacks. Some people find it effective, but responses vary. Common side effects include infections, rash, and injection site reactions. Serious risks include severe infections Show Full Answer

Cimzia (certolizumab pegol) is a biologic DMARD used to treat rheumatoid arthritis. It works by inhibiting TNF-α, a chemical involved in autoimmune attacks. Some people find it effective, but responses vary. Common side effects include infections, rash, and injection site reactions. Serious risks include severe infections, cancer, and nerve damage. Always discuss with your doctor to weigh benefits and risks. For more, visit: url: https://www.myrateam.com/treatments/cimzia.

 This AI-generated response comes from myRAteam and other selected sources. It is not a substitute for medical advice. Always ask your doctor about specific health concerns.

Cimzia (Certolizumab pegol) for Rheumatoid Arthritis | myRAteam

TNFi Biologics (Humira®, Cimzia®, Enbrel®, Simponi®, Remicade®)